or Try an Advanced Search...

    Technical Analysis for TSVT - 2seventy bio, Inc.

    Grade Last Price % Change Price Change
    F 4.52 -2.59% -0.12
    TSVT closed down 2.59 percent on Friday, April 19, 2024, on 51 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 1
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical TSVT trend table...
    Date Alert Name Type % Chg
    200 DMA Resistance Bearish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    BB Squeeze + Lower Band Touch Range Contraction 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Fell Below 200 DMA Bearish -2.59%
    MACD Bearish Centerline Cross Bearish -2.59%
    Bollinger Band Squeeze Range Contraction -2.59%
    Oversold Stochastic Weakness -2.59%
    20 DMA Resistance Bearish -10.67%
    Older End-of-Day Signals for TSVT ...

       Recent Intraday Alerts

    Alert Time
    Lower Bollinger Band Support about 8 hours ago
    Down 3% about 8 hours ago
    Down 2 % about 9 hours ago
    60 Minute Opening Range Breakdown about 9 hours ago
    Fell Below Lower Bollinger Band about 9 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    TSVT Chart by TradingView
    Basic chart:

    Profile

    2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts. 2seventy bio, Inc. operates independently of bluebird bio, Inc. as of November 4, 2021.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Life Sciences Gene Therapy Multiple Myeloma Breakthrough Therapy Chimeric Antigen Receptor T Cell

    Is TSVT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 5 Bristol Myers, 2seventy bio's Abecma approved for earlier line multiple myeloma
    Apr 5 U.S. FDA Approves Bristol Myers Squibb and 2seventy bio’s Abecma for Triple-Class Exposed Relapsed or Refractory Multiple Myeloma After Two Prior Lines of Therapy
    Apr 3 2seventy Bio: Maximizing ABECMA's Potential To Fuel A Turnaround
    Apr 1 2seventy bio Announces Completion of Oncology and Autoimmune Pipeline Divestiture to Regeneron
    Mar 20 2seventy bio appoints Eli Casdin and Charles Newton to its board of directors
    Mar 20 2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors
    Mar 16 Bristol Myers wins FDA AdCom backing for Abecma label expansion
    Mar 15 FDA Advisory Committee Votes in Favor of Bristol Myers Squibb’s and 2seventy bio’s Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy
    Mar 7 Downgrade: Here's How Analysts See 2seventy bio, Inc. (NASDAQ:TSVT) Performing In The Near Term
    Mar 6 When Will 2seventy bio, Inc. (NASDAQ:TSVT) Turn A Profit?
    See more TSVT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.69
    52 Week Low 1.535
    Average Volume 1,193,367
    200-Day Moving Average 4.75
    50-Day Moving Average 5.19
    20-Day Moving Average 5.12
    10-Day Moving Average 5.10
    Average True Range 0.48
    RSI (14) 42.53
    ADX 21.66
    +DI 21.56
    -DI 22.17
    Chandelier Exit (Long, 3 ATRs) 4.55
    Chandelier Exit (Short, 3 ATRs) 5.73
    Upper Bollinger Bands 5.75
    Lower Bollinger Band 4.48
    Percent B (%b) 0.03
    BandWidth 24.83
    MACD Line -0.05
    MACD Signal Line 0.03
    MACD Histogram -0.076
    Fundamentals Value
    Market Cap 228.82 Million
    Num Shares 50.6 Million
    EPS -3.77
    Price-to-Earnings (P/E) Ratio -1.20
    Price-to-Sales 2.08
    Price-to-Book 0.99
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.98
    Resistance 3 (R3) 5.01 4.88 4.90
    Resistance 2 (R2) 4.88 4.77 4.87 4.88
    Resistance 1 (R1) 4.70 4.69 4.64 4.67 4.85
    Pivot Point 4.58 4.58 4.55 4.56 4.58
    Support 1 (S1) 4.40 4.46 4.34 4.37 4.19
    Support 2 (S2) 4.27 4.39 4.26 4.16
    Support 3 (S3) 4.09 4.27 4.14
    Support 4 (S4) 4.06